Copper induces the accumulation of amyloid-beta in the brain

Molecular and Cellular Toxicology

Volumn 9, Issue 1, 2013, Pages 57-66

  Kim, Dong Kyeong ^a   Song, Ji Won ^a   Park, Jung Duck ^a   Choi, Byung Sun ^a  

^a Chung Ang University   (South Korea)

Author keywords

Amyloid beta protein; Amyloid precursor protein (APP); Beta site APP cleaving enzyme 1 (BACE1); Blood brain barrier (BBB); Blood CSF barrier (BCB); Copper; Low density lipoprotein receptor related protein 1 (LRP1); Neprilysin (NEP); Receptor for advanced glycation end products (RAGE)

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; COPPER; COPPER SULFATE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; NONHUMAN; PC12 CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 84875836926     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-013-0009-0     Document Type: Article

References (48)

1. Mattson, M. P. Pathways towards and away from Alzheimer's disease. Nature 430:631-639 (2004).
2. Lesne, S. et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352-357 (2006).
3. Bush, A. I., Masters, C. L. & Tanzi, R. E. Copper, betaamyloid, and Alzheimer's disease: tapping a sensitive connection. Proc Natl Acad Sci USA 100:11193-11194 (2003).
4. Huang, X. et al. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J Biol Inorg Chem 9:954-960 (2004).
5. Mattson, M. P. Gene-diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med 139:441-444 (2003).
6. Raman, B. et al. Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid {beta} peptide. J Biol Chem 280:16157-16162 (2005).
7. Martorana, A. et al. Cerebrospinal fluid levels of Abeta42 relationship with cholinergic cortical activity in Alzheimer's disease patients. J Neural Transm. http://link.springer.com/content/pdf/10.1007%2Fs00702-012-0780-4 (2012).
8. Ogomori, K. et al. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol 134:243-251 (1989).
9. Selkoe, D. J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8:447-453 (1998).
10. Deane, R., Bell, R. D., Sagare, A. & Zlokovic, B. V. Clearance of amyloid-beta peptide across the bloodbrain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets 8:16-30 (2009).
11. Donnelly, P. S., Xiao, Z. & Wedd, A. G. Copper and Alzheimer's disease. Curr Opin Chem Biol 11:128-133 (2007).
12. Hung, Y. H., Bush, A. I. & Cherny, R. A. Copper in the brain and Alzheimer's disease. J Biol Inorg Chem 15:61-76 (2010).
13. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L. & Markesbery, M. R. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158:47-52 (1998).
14. Huang, X., Moir, R. D., Tanzi, R. E., Bush, A. I. & Rogers, J. T. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci 1012:153-163 (2004).
15. Angeletti, B. et al. BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper. J Biol Chem 280:17930-17937 (2005).
16. Atwood, C. S. et al. Copper mediates dityrosine crosslinking of Alzheimer's amyloid-beta. Biochemistry 43:560-568 (2004).
17. Hesse, L., Beher, D., Masters, C. L. & Multhaup, G. The beta A4 amyloid precursor protein binding to copper. FEBS Lett 349:109-116 (1994).
18. Multhaup, G. et al. The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science 271:1406-1409 (1996).
19. Multhaup, G. et al. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry 37:7224-7230 (1998).
20. White, A. R. et al. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842:439-444 (1999).
21. Acevedo, K. M. et al. Copper promotes the trafficking of the amyloid precursor protein. J Biol Chem 286:8252-8262 (2011).
22. Shirotani, K. et al. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon- sensitive endopeptidases. J Biol Chem 276:21895-21901 (2001).
23. Maruyama, M. et al. Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease. Ann Neurol 57:832-842 (2005).
24. Yasojima, K., Akiyama, H., McGeer, E. G. & McGeer, P. L. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett 297:97-100 (2001).
25. Li, M. et al. Copper downregulates neprilysin activity through modulation of neprilysin degradation. J Alzheimers Dis 19:161-169 (2010).
26. Choi, B. S. & Zheng, W. Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res 1248:14-21 (2009).
27. Zlokovic, B. V. et al. Blood-brain barrier transport of circulating Alzheimer's amyloid beta. Biochem Biophys Res Commun 197:1034-1040 (1993).
28. Behl, M., Zhang, Y., Monnot, A. D., Jiang, W. & Zheng, W. Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1. Toxicol Appl Pharmacol 240:245-254 (2009).
29. Rubenstein, E. Relationship of senescence of cerebrospinal fluid circulatory system to dementias of the aged. Lancet 351:283-285 (1998).
30. Selkoe, D. J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 924:17-25 (2000).
31. Shibata, M. et al. Clearance of Alzheimer's amyloidss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489-1499 (2000).
32. Donahue, J. E. et al. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 112:405-415 (2006).
33. Miller, M. C. et al. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res 1230:273-280 (2008).
34. Yan, S. D. et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691 (1996).
35. Sparks, D. L. & Schreurs, B. G. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci USA 100:11065-11069 (2003).
36. Selkoe, D. J. & Schenk, D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43:545-584 (2003).
37. Selkoe, D. J. Clearing the brain's amyloid cobwebs. Neuron 32:177-180 (2001).
38. Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178-201 (2008).
39. Prelli, F. et al. Different processing of Alzheimer's beta-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Biochem Biophys Res Commun 151:1150-1155 (1988).
40. Seubert, P. et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359:325-327 (1992).
41. Rivera-Mancia, S. et al. The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact 186:184-199 (2010).
42. Gerhardsson, L., Lundh, T., Minthon, L. & Londos, E. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 25:508-515 (2008).
43. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L. & Markesbery, W. R. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158:47-52 (1998).
44. Lin, R. et al. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin. Neurosci Lett 440:344-347 (2008).
45. Varela-Nallar, L. et al. Induction of cellular prion protein gene expression by copper in neurons. Am J Physiol Cell Physiol 290:C271-281 (2006).
46. Lin, R. et al. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin. Neurosci Lett 440:344-347 (2008).
47. Andersen, C. L., Jensen, J. L. & Orntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245-5250 (2004).
48. Pfaffl, M. W., Tichopad, A., Prgomet, C. & Neuvians, T. P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 26:509-515 (2004).